MRNA stock

GBS Stock
Industry

Moderna Inc [MRNA] moved up 6.19: Why It’s Important

Moderna Inc [NASDAQ: MRNA] closed the trading session at $111.60. The company report on April 3, 2024 at 11:00 AM that Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature. Moderna, Inc. (NASDAQ:MRNA) today announced that interim

Market

Market Analysts see Moderna Inc [MRNA] gaining to $86. Time to buy?

Moderna Inc [NASDAQ: MRNA] jumped around 3.18 points on Wednesday, while shares priced at $110.59 at the close of the session, up 2.96%. The company report on March 27, 2024 at 6:30 AM that Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials. Announces next-generation

NFLX Stock
Finance

Moderna Inc [MRNA] moved up 13.53: Why It’s Important

Moderna Inc [NASDAQ: MRNA] surged by $11.85 during the normal trading session on while it closed the day at $99.44. The company report on February 22, 2024 at 6:30 AM that Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates.